NCT03569085View on ClinicalTrials.gov

Inhaled Anesthetics and Myocardial Strain

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

June 27, 2018

Primary Completion Date

December 6, 2018

Study Completion Date

May 4, 2023

Conditions
Heart Diseases
Interventions
DRUG

Sevoflurane

The patient will receive Sevoflurane in incremental doses titrated to obtain end-tidal minimum alveolar concentration (MAC) of 0.5, 1.0, and 1.5.

DRUG

Isoflurane

The patient will receive isoflurane in incremental doses titrated to obtain end-tidal minimum alveolar concentration (MAC) of 0.5, 1.0, and 1.5.

Trial Locations (1)

15213

UPMC Presbyterian Hospital, Pittsburgh

All Listed Sponsors
lead

Kathirvel Subramaniam

OTHER

NCT03569085 - Inhaled Anesthetics and Myocardial Strain | Biotech Hunter | Biotech Hunter